Morgan Stanley’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-10,412
| Closed | -$6K | – | 6924 |
|
|
2019
Q4 | $6K | Buy |
10,412
+6,940
| +200% | +$4K | ﹤0.01% | 6387 |
|
|
2019
Q3 | $14K | Sell |
3,472
-7,350
| -68% | -$29.6K | ﹤0.01% | 6119 |
|
|
2019
Q2 | $72K | Buy |
10,822
+4,906
| +83% | +$32.6K | ﹤0.01% | 5467 |
|
|
2019
Q1 | $21K | Sell |
5,916
-7,075
| -54% | -$25.1K | ﹤0.01% | 6004 |
|
|
2018
Q4 | $51K | Sell |
12,991
-14,853
| -53% | -$58.3K | ﹤0.01% | 5761 |
|
|
2018
Q3 | $550K | Buy |
27,844
+14,360
| +106% | +$284K | ﹤0.01% | 4948 |
|
|
2018
Q2 | $428K | Sell |
13,484
-784
| -5% | -$24.9K | ﹤0.01% | 5203 |
|
|
2018
Q1 | $527K | Buy |
14,268
+5,724
| +67% | +$211K | ﹤0.01% | 4970 |
|
|
2017
Q4 | $675K | Buy |
+8,544
| New | +$675K | ﹤0.01% | 4803 |
|